Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange on April 17th, 2026, Beijing Time.
"News organizations will increasingly rely on digital creators not just as amplifiers but as integral partners in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results